| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |